SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joe E. who wrote (2674)11/6/1997 11:15:00 PM
From: JOHN W.   of 6136
 
Yes, it is very likely it will take a few more weeks as originally thought, Elise must have rcvd this word because I noticed she has the Q1 time for approval. L. Moss' post:
Subject: Euro approval
Date: Thu, Nov 6, 1997 16:24 EST
From: LMoss
Message-id:

Agouron CEO Peter Johnson stated at the annual meeting today that European approval to sell Viracept was expected in the first calendar quarter of 1998.

Late January or early February would be my best estimate.

LMoss

I agree with a conservative estimate of late Jan.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News